In conclusion our data support the finding that over 60% of OFD1 patients show neurodevelopmental defects including brain structural anomalies, cognitive impairment (borderline intelligence, mild to severe intellectual disability and selective cognitive defects), and associated neurological disorders and signs. This evidence concerns the gene OFD1 and Intellectual disability.